Supreme Court declines to hear Teva generics case; insurer tussle puts care denials front and center

Taking stock of the drug industry, from the lab to the medicine chest

May 15, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | U.S. Supreme Court declines bid by Teva to hear 'skinny labeling' case with implications for generic drug access The Supreme Court declined to hear an appeal of a case on "skinny labeling," which generic drugmakers use to bring medicines to market. By Ed Silverman Biden nominates Monica Bertagnolli to head NIH Biden announced he would nominate National Cancer Institute Director Monica Bertagnolli to fill the long-vacant director slot at NIH. By Sarah Owermohle STAT+ | Envision Healthcare files for bankruptcy Physician staffing firm Envision Healthcare officially filed for bankruptcy on Monday, a move that will wipe away $5.6 billion of debt. By Bob Herman Adobe STAT+ | Hospital-insurer tussle in Arizona puts care denials front and center A dispute between UnitedHealthcare and the hospital is more about too many care denials than too low payment rates, the hospital argues. By Bob Herman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser